Everest Medicines Limited (1952.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.11B |
| Enterprise Value | 9.31B |
| P/E Ratio | -155.14 |
| PEG Ratio | -0.48 |
| Price/Sales Ratio | 3.58 |
| Price/Book Ratio | 1.39 |
| Enterprise/Revenue | 3.77 |
| Enterprise/EBITDA | 233.98 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.02 |
| Operating Margin | -0.05 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 1.71B |
| Revenue/Share | 8.1 |
| Gross Profit | 1.18B |
| EBITDA | -211.18M |
| Net Income | -297.77M |
| Diluted EPS | -0.89 |
Balance Sheet
| Total Cash | 2.04B |
| Total Cash/Share | 6.25 |
| Total Debt | 1.99B |
| Total Debt/Equity | 0.38 |
| Current Ratio | 3.77 |
| Book Value Per Share | 17.6 |
Price History
| 52-Week Change | -50.19 |
| 52-Week High | 58.45 |
| 52-Week Low | 22.7 |
| Moving Average 50 Days | 28.95 |
| Moving Average 200 Days | 33.55 |
Statistics
| Average Volume | 8.42M |
| Shares Outstanding | 351.34M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
